计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| S125282-10mg |
10mg |
现货 ![]() |
| |
| S125282-50mg |
50mg |
现货 ![]() |
| |
| S125282-250mg |
250mg |
现货 ![]() |
| |
| S125282-1g |
1g |
现货 ![]() |
| |
| S125282-5g |
5g |
现货 ![]() |
|
| 别名 | 沙芬酰胺 | 沙非酰胺 |
|---|---|
| 英文别名 | DTXCID701436700 | CHEBI:134718 | D10158 | (S)-2[4-(3-fluorobenzyloxy)benzylamino] propanamide | BDBM50078694 | Q2211523 | SAFINAMIDE [INN] | 2(S)-[4-(3-Fluorobenzyloxy) benzylamino] propionamide | NEMGRZFTLSKBAP-LBPRGKRZSA-N | EMD 1195686;FCE 26743;EMD-11 |
| 规格或纯度 | Moligand™, ≥98% |
| 英文名称 | Safinamide |
| 生化机理 | 沙芬那胺是一种高选择性和可逆的单胺氧化酶 B 型(MAO-B)抑制剂,可增加新纹状体多巴胺浓度。此外,沙芬那胺还是电压依赖性钠和钙通道阻滞剂。沙芬胺似乎与电压敏感钠通道的蝙蝠毒素敏感位点 2 结合。沙芬胺能阻断 N 型和 L 型钙通道,抑制突触末端释放谷氨酸和天冬氨酸。 |
| 储存温度 | 2-8°C储存 |
| 运输条件 | 冰袋运输 |
| 作用类型 | 抑制剂 |
| 作用机制 | 单胺氧化酶 B 抑制剂 |
| 产品介绍 |
Safinamide (EMD 1195686; FCE 26743)是可逆的MAO-B抑制剂,IC50为98 nM,比对MAO-A的抑制性高5918倍。 Safinamide (EMD 1195686; FCE 26743) selectively and reversibly inhibits MAO-B with IC50 of 98 nM, exhibits 5918-fold selectivity against MAO-A. |
| 纯度 | ≥98% |
| ALogP | 2.2 |
|---|
| PubChem SID | 504757009 |
|---|---|
| 分子类型 | 小分子 |
| IIUPAC Name | (2S)-2-[[4-[(3-fluorophenyl)methoxy]phenyl]methylamino]propanamide |
| INCHI | 1S/C17H19FN2O2/c1-12(17(19)21)20-10-13-5-7-16(8-6-13)22-11-14-3-2-4-15(18)9-14/h2-9,12,20H,10-11H2,1H3,(H2,19,21)/t12-/m0/s1 |
| InChi Key | NEMGRZFTLSKBAP-LBPRGKRZSA-N |
| Smiles | CC(C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F |
| Isomeric SMILES | C[C@@H](C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F |
| PubChem CID | 131682 |
| 分子量 | 302.34 |
| 溶解性 | DMSO |
|---|---|
| 敏感性 | 对热敏感 |
| 熔点 | 212°C |
| 分子量 | 302.340 g/mol |
| XLogP3 | 2.200 |
| 氢键供体数Hydrogen Bond Donor Count | 2 |
| 氢键受体数Hydrogen Bond Acceptor Count | 4 |
| 可旋转键计数Rotatable Bond Count | 7 |
| 精确质量Exact Mass | 302.143 Da |
| 单同位素质量Monoisotopic Mass | 302.143 Da |
| 拓扑极表面积Topological Polar Surface Area | 64.400 Ų |
| 重原子数Heavy Atom Count | 22 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 346.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 1 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 1. Caccia C, Maj R, Calabresi M, Maestroni S, Faravelli L, Curatolo L, Salvati P, Fariello RG. (2006) Safinamide: from molecular targets to a new anti-Parkinson drug.. Neurology, 67 (7 Suppl 2): (S18-23). [PMID:17030736] |
| 2. Binda C, Wang J, Pisani L, Caccia C, Carotti A, Salvati P, Edmondson DE, Mattevi A. (2007) Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs.. J Med Chem, 50 (23): (5848-52). [PMID:17915852] |
| 3. Yi-Kao Hu, Yi-Ming Liu, Xiao-Lin Bai, Chao Ma, Xun Liao. (2023) Screening of Monoamine Oxidase B Inhibitors from Fragaria nubicola by Ligand Fishing and Their Neuroprotective Effects. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 71 (1): (512–521). [PMID:36562659] [10.1021/acs.jafc.2c06630] |